Pharma News: Eli Lilly Earnings, AstraZeneca Receives Drug Approval

66 views
  • About
  • Add to
Eli Lilly (LLY) reported a decline in second quarter earnings today. Profits fell to $1.2 billion, or $1.07 per share, from $1.35 billion, or $1.22 per share, in last years second quarter.

0 comments